Institutional career development core

Active Project Grant Awarded Last action

Award ID
KL2TR001882
Recipient
Awarding agency
Obligated
$22,239,909

Award facts

Completion date 95% complete
Originally
Funding
  • $20,691,783.04 Federal
  • $1,548,126.00 Non-federal
Place of performance
Los Angeles, CA 90095, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $1,263,600 $0
Amendment $1,263,600 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,013,600 $0
Amendment $1,013,600 $0
Amendment Institutional career development core - the proposed ucla ctsi KL2 grant builds upon long-standing relationships among our ctsi institution partners - ucla,… $1,013,600 $0
Amendment $0 $0
Amendment $1,263,600 $0
Amendment Institutional career development core - contact PD/PI: dubinett, steven M. Inst-career-DEV-001 (671) I. Institutional career development core summary/abstract… $1,263,600 $0
Amendment $1,263,600 $0
Amendment $1,263,600 $0
Amendment Institutional career development core - contact PD/PI: dubinett, steven M. Inst-career-DEV-001 (671) I. Institutional career development core summary/abstract… $142,263 $0
Amendment $28,844 $0
Amendment Institutional career development core - contact PD/PI: dubinett, steven M. Inst-career-DEV-001 (671) I. Institutional career development core summary/abstract… -$28,844 $0
Amendment -$28,844 $0
Amendment -$28,844 $0
Amendment $142,263 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,263,600 $0
Amendment $1,263,600 $1,263,600
Amendment -$142,263 $0
Amendment $142,263 $0
Amendment $142,263 $0
Amendment $142,263 $142,263
Amendment -$142,263 $0
Amendment $142,263 $0
Amendment -$142,263 $0
Amendment $142,263 $142,263
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $142,263 $0
Amendment $1,260,720 $0
Amendment $0 $0
Amendment -$142,263 $0
Amendment $142,263 $0
Amendment $142,263 $0
Amendment $147,558 $0
Amendment $1,260,720 $0
Amendment -$147,576 $0
Amendment $147,576 $0
Amendment $1,408,296 $0
Amendment The effect of nanoparticle encapsulated resveratrol on treatment of periodontitis $147,560 $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
Charles R. Drew University Of Medicine And Science PI to carry out the project activities described in the research strategy, including longitudinal analyses using the ABCD Study dataset, neuroimaging training… $131,391
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center The skin is one of the main portals of entry for severe invasive infections. Staphylococcus aureus (SA) is the most common cause of acute skin and soft tissue… $210,600
Cedars-Sinai Medical Center Parkinson's disease (PD) is a complex neurodegenerative disorder with unclear etiology and limited treatment options. While environmental factors likely… $272,025
Cedars-Sinai Medical Center Dr. Kwan will serve as Principal Investigator for the proposed study, assuming responsibility for ensuring the successful completion of the project aims. He… $280,801
Cedars-Sinai Medical Center Parkinson's disease (PD) is a complex neurodegenerative disorder with unclear etiology and limited treatment options. While environmental factors likely… $436,416
Charles R. Drew University Of Medicine And Science Triple negative breast cancer (TNBC) is an aggressive form of breast cancer with a significant health disparity. It disproportionately affects… $416,874
Cedars-Sinai Medical Center Specific Aim 1: Identify spatial and functional immune subtypes in DLBCL that predict clinical outcomes. Subaim 1a: The goal is to validate preliminary findings… $8,984
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center AIM 1. To identify novel C. auris cell surface proteins, determine their immunodominant traits, and test their role in virulence. We identified three C.… $14,316
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center AIM 1. To identify novel C. auris cell surface proteins, determine their immunodominant traits, and test their role in virulence. We identified three C.… $131,254
Cedars-Sinai Medical Center This training plans to capitalize on an exceptional mentorship team and translational research environment to foster he candidate's expertise 1.) large scale… $438,434
Cedars-Sinai Medical Center The following specific aims are proposed to test our overall hypothesis: Aim 1) We will define transcriptome signatures of cellular senescence in idiopathic… $122,035
Cedars-Sinai Medical Center Specific Aim 1: Identify spatial and functional immune subtypes in DLBCL that predict clinical outcomes. Subaim 1a: The goal is to validate preliminary findings… $280,800
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center Specific Aim 1: Define the Mechanisms and Specificity of MCI> Anti-Staphylococcal Memory. Our preliminary data indicate epigenetic mechanisms are integral to… $140,400
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center AIM 1. To identify novel C. auris cell surface proteins, determine their immunodominant traits, and test their role in virulence. We identified three C.… $285,970
Show all 14

Quick answers

Who received award KL2TR001882?

KL2TR001882 was awarded to University Of California, LOS Angeles by National Center for Advancing Translational Sciences (National Institutes of Health) on July 1, 2016.

How much is award KL2TR001882 worth?

$22,239,909 has been obligated on KL2TR001882: $20,691,783 in federal funding and $1,548,126 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login